SCHEMBL220236

SCHEMBL220236

O=C1C=CCc2nnn(O)c21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8189032 0.79
SCHEMBL11327997 0.78 TOP2A (0.36)
SCHEMBL4057013 0.66 POLB (0.30)
Water SCHEMBL1720810 0.64
SCHEMBL593947 0.57
SCHEMBL11881836 0.57
SCHEMBL447698 0.55
SCHEMBL12033685 0.55
SCHEMBL2069026 0.54
SCHEMBL1980267 0.54

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 396 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2912074-B2 DERMAL INJECTABLE STERILE COMPOSITION TEOXANE (CH) 2021-12-22 EP claimed
CN-111732675-A Hyaluronic acid-glucosamine graft copolymer, preparation method and application thereof 山东华熙海御生物医药有限公司 2020-10-02 CN claimed
EP-3648775-A1 BICONJUGATES WITH CHEMICALLY MODIFIED BACKBONES Symic IP, LLC (US) 2020-05-13 EP claimed
CN-111050778-A Bioconjugates with chemically modified backbones 斯米克IP有限公司 2020-04-21 CN claimed
EP-2912074-B1 DERMAL INJECTABLE STERILE COMPOSITION TEOXANE (CH) 2019-05-01 EP claimed
WO-2019010490-A1 BICONJUGATES WITH CHEMICALLY MODIFIED BACKBONES SYMIC IP, LLC (US) 2019-01-10 WO claimed
US-9907739-B2 Dermal injectable sterile composition TEOXANE (CH) 2018-03-06 US claimed
US-20150272851-A1 DERMAL INJECTABLE STERILE COMPOSITION TEOXANE (CH) 2015-10-01 US claimed
EP-2912074-A1 DERMAL INJECTABLE STERILE COMPOSITION Teoxane (CH) 2015-09-02 EP claimed
WO-2014064632-A1 DERMAL INJECTABLE STERILE COMPOSITION TEOXANE (CH) 2014-05-01 WO claimed
EP-2403830-A2 INDOLE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES Centre National de la Recherche Scientifique (CNRS) (FR) 2012-01-11 EP claimed
US-20110319387-A1 INDOLE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2011-12-29 US claimed
EP-2379484-A1 POLYUNSATURATED FATTY ACID AND DIOL ESTER AS AN ANTI-ACNE AGENT Pierre Fabre Dermo-Cosmétique (FR) 2011-10-26 EP claimed
US-20110230557-A1 POLYUNSATURATED FATTY ACID AND DIOL ESTER AS AN ANTI-ACNE AGENT PIERRE FABRE DERMO-COSMETIQUE (FR) 2011-09-22 US claimed
CN-1968708-B Medicine containing avocado peptide extract for treating and preventing diseases related to immune system deficiency EXPANSCIENCE LAB 2011-07-27 CN claimed
WO-2010100133-A2 INDOLE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2010-09-10 WO claimed
WO-2010072738-A1 POLYUNSATURATED FATTY ACID AND DIOL ESTER AS AN ANTI-ACNE AGENT PIERRE FABRE DERMO-COSMETIQUE (FR) 2010-07-01 WO claimed
US-20090263447-A1 Crosslinked hyaluronic acid and process for the preparation thereof STIEFEL LABORATORIES, INC. (US) 2009-10-22 US claimed
WO-2006021644-A1 WATER-SOLUBLE CROSSLINKED HYALURONIC ACID, A METHOD FOR THE PREPARATION THEREOF, IMPLANT CONTAINING SAID CROSSLINKED HYALURONIC ACID AND THE USE THEREOF ASIUS JEROME (FR) 2006-03-02 WO claimed
US-4087283-A CARBODIIMIDE AND N-HYDROXY CYCLIC AMINE GAF CORPORATION (US) 1978-05-02 US claimed